NCT02892773

Brief Summary

The purpose of this study is to better understand how air is spread throughout study participants' lungs after abdominal surgery by comparing two lung inflation treatments:

  1. 1.Incentive Spirometry (I.S.) lung expansion therapy
  2. 2.EzPAP® lung expansion therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 8, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2018

Completed
Last Updated

November 19, 2018

Status Verified

November 1, 2018

Enrollment Period

1.9 years

First QC Date

August 28, 2016

Last Update Submit

November 16, 2018

Conditions

Keywords

electrical impedance tomographyincentive spirometryEzPAPlung volumeatelectasispositive airway pressurepulmonary complicationabdominal surgeryend-expiratory lung volume

Outcome Measures

Primary Outcomes (1)

  • Ventral and Dorsal end-expiratory lung impedance redistribution of ventilation

    EIT will be used to measure ventral and dorsal change in end-expiratory lung impedance before and after lung expansion therapy. Ventral and Dorsal lung impedance measurement is displayed on the EIT device as a percent (zero to 100). Investigators will record values into an electronic code book before and after lung expansion therapy. The difference between measured values will be used to quantify ventral and dorsal redistribution of ventilation. * Statistical analysis * An independent samples t-test or Mann-Whitney U test will be applied to determine if a statistically significant mean difference exists between groups. * Data will be reported as mean (SD) and 95% CI or median (IQR) depending upon normality of distribution. * Effect size = r (small effect \</= 0.1; medium effect = 0.3; Large effect \>/= 0.5 * Alpha set at ≤ 0.05 (two-tailed)

    Two years

Secondary Outcomes (1)

  • Incidences of post-operative pulmonary complications

    Two years

Study Arms (2)

Incentive Spirometry Group

OTHER

* Participant will be asked to take 10 deep breaths through the mouthpiece of an incentive spirometer, followed by a 60 second pause. * This cycle will be repeated two more times. * A Respiratory Therapist will coach participants three times per day. * Each duration of Incentive Spirometry will last about 15 minutes.

Device: Incentive Spirometry

EzPAP® Positive Airway Pressure Group

ACTIVE COMPARATOR

* Participant will be coached by a Respiratory Therapist to breathe through the mouthpiece of an EzPAP® device for 10 breaths, followed by a 60 second pause. * This cycle will be repeated two more times. * The Respiratory Therapist will coach participants three times per day. * Each duration of EzPAP® therapy will last about 15 minutes.

Device: EzPAP® Positive Airway Pressure

Interventions

A respiratory therapist will provide instruction on Incentive Spirometry (I.S.) procedure performance before supervised therapy and monitoring begins. * Study participants will be asked to take 10 deep breaths through the I.S.'s mouthpiece, followed by a 60 second pause. * The 10-breath cycle will be repeated 3 times per therapy session. * Each I.S. therapy session will last about 15 minutes, 3 times per day. * Lung monitoring and deep breathing measurements will occur during a scheduled I.S. sessions on day 1, 3, and 5 after surgery.

Incentive Spirometry Group

A respiratory therapist will provide instruction on EzPAP® procedure performance before supervised therapy and monitoring begins. * Study participants will be asked to breathe normally through the EzPAP® device's mouthpiece for 10 breaths, followed by a 60 second pause. * The 10-breath cycle will be repeated 3 times. * Each EzPAP® therapy sessions will last about 15 minutes, 3 times per day. * Lung monitoring will occur during a scheduled EzPAP® sessions on day 1, 3, and 5 after surgery.

EzPAP® Positive Airway Pressure Group

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Human subjects 18 - 79 years of age
  • Post-operative upper abdominal surgery
  • Examples:
  • Laparotomy
  • Biliodigestive anastomosis
  • Cholecystectomy
  • Enterectomy
  • Esophagectomy
  • Gastrectomy
  • Hepatectomy
  • Pancreatectomy
  • Unassisted spontaneous breathing
  • Attending surgeon's approval
  • Anticipated post-operative hospital length of stay greater than 3 days
  • Documentation of written informed consent
  • +1 more criteria

You may not qualify if:

  • Less than 18 or greater than 79 years of age
  • Anticipated post-operative hospital length of stay less than 3 days
  • Body mass index \> 50
  • Excessive chest hair
  • Inability to obtain written informed consent
  • Inability to follow verbal instructions
  • Pregnancy-self reported
  • uncontrolled body movements
  • Insertion of an artificial airway
  • Hemodynamic instability
  • Loss of skin integrity at site where EIT electrodes and belt are projected to come into contact (i.e., chest burns, open wounds/lesions, etc…).
  • Chest tube or dressings that prohibit placement of EIT electrodes and belt
  • Active implants (i.e., cardiac pacemaker, implantable cardioverter-defibrillator \[ICD\]), diaphragm pacer, or when device compatibility is in doubt.)
  • Invasive or non-invasive mechanical ventilation support
  • Unstable spinal lesions or fractures
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia Medical Center

Charlottesville, Virginia, 22903, United States

Location

Related Publications (12)

  • do Nascimento Junior P, Modolo NS, Andrade S, Guimaraes MM, Braz LG, El Dib R. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. Cochrane Database Syst Rev. 2014 Feb 8;2014(2):CD006058. doi: 10.1002/14651858.CD006058.pub3.

    PMID: 24510642BACKGROUND
  • Fagevik Olsen M, Wennberg E, Johnsson E, Josefson K, Lonroth H, Lundell L. Randomized clinical study of the prevention of pulmonary complications after thoracoabdominal resection by two different breathing techniques. Br J Surg. 2002 Oct;89(10):1228-34. doi: 10.1046/j.1365-2168.2002.02207.x.

    PMID: 12296888BACKGROUND
  • Garrard CS, Shah M. The effects of expiratory positive airway pressure on functional residual capacity in normal subjects. Crit Care Med. 1978 Sep-Oct;6(5):320-2. doi: 10.1097/00003246-197809000-00004.

    PMID: 363357BACKGROUND
  • Hinz J, Neumann P, Dudykevych T, Andersson LG, Wrigge H, Burchardi H, Hedenstierna G. Regional ventilation by electrical impedance tomography: a comparison with ventilation scintigraphy in pigs. Chest. 2003 Jul;124(1):314-22. doi: 10.1378/chest.124.1.314.

    PMID: 12853539BACKGROUND
  • Karsten J, Stueber T, Voigt N, Teschner E, Heinze H. Influence of different electrode belt positions on electrical impedance tomography imaging of regional ventilation: a prospective observational study. Crit Care. 2016 Jan 8;20:3. doi: 10.1186/s13054-015-1161-9.

    PMID: 26743570BACKGROUND
  • Lunardi AC, Paisani DM, Silva CCBMD, Cano DP, Tanaka C, Carvalho CRF. Comparison of lung expansion techniques on thoracoabdominal mechanics and incidence of pulmonary complications after upper abdominal surgery: a randomized and controlled trial. Chest. 2015 Oct;148(4):1003-1010. doi: 10.1378/chest.14-2696.

    PMID: 25973670BACKGROUND
  • Meier T, Luepschen H, Karsten J, Leibecke T, Grossherr M, Gehring H, Leonhardt S. Assessment of regional lung recruitment and derecruitment during a PEEP trial based on electrical impedance tomography. Intensive Care Med. 2008 Mar;34(3):543-50. doi: 10.1007/s00134-007-0786-9. Epub 2007 Jul 25.

    PMID: 17653529BACKGROUND
  • Parke RL, Bloch A, McGuinness SP. Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers. Respir Care. 2015 Oct;60(10):1397-403. doi: 10.4187/respcare.04028. Epub 2015 Sep 1.

    PMID: 26329355BACKGROUND
  • Riedel T, Richards T, Schibler A. The value of electrical impedance tomography in assessing the effect of body position and positive airway pressures on regional lung ventilation in spontaneously breathing subjects. Intensive Care Med. 2005 Nov;31(11):1522-8. doi: 10.1007/s00134-005-2734-x. Epub 2005 Sep 30.

    PMID: 16195908BACKGROUND
  • Stankiewicz-Rudnicki M, Gaszynski T, Gaszynski W. Assessment of regional ventilation in acute respiratory distress syndrome by electrical impedance tomography. Anaesthesiol Intensive Ther. 2015;47(1):77-81. doi: 10.5603/AIT.2015.0007.

    PMID: 25751294BACKGROUND
  • Westerdahl E, Lindmark B, Eriksson T, Friberg O, Hedenstierna G, Tenling A. Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery. Chest. 2005 Nov;128(5):3482-8. doi: 10.1378/chest.128.5.3482.

    PMID: 16304303BACKGROUND
  • Rowley DD, Malinowski TP, Di Peppe JL, Sharkey RM, Gochenour DU, Enfield KB. A Randomized Controlled Trial Comparing Two Lung Expansion Therapies After Upper Abdominal Surgery. Respir Care. 2019 Oct;64(10):1181-1192. doi: 10.4187/respcare.06812. Epub 2019 May 21.

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Daniel D Rowley, MSc RRT-ACCS

    Pulmonary Diagnostics & Respiratory Therapy Services, University of Virginia Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participant and Care Provider will be masked from electrical impedance tomography distribution of ventilation recording during lung expansion therapy to reduce risk of performance bias.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc RRT-ACCS

Study Record Dates

First Submitted

August 28, 2016

First Posted

September 8, 2016

Study Start

January 1, 2017

Primary Completion

November 12, 2018

Study Completion

November 12, 2018

Last Updated

November 19, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will share

Intend to submit overall study findings to peer reviewed medical journal after study completion.

Locations